These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors related to the severity of tardive dyskinesia. Wade JB; Hart RP; Dougherty LM Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823 [TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Lohr JB; Caligiuri MP J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552 [TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature. Yassa R; Camille Y; Belzile L J Clin Psychopharmacol; 1987 Aug; 7(4):243-6. PubMed ID: 3624506 [TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. Ghadirian AM; Annable L; Bélanger MC; Chouinard G J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543 [TBL] [Abstract][Full Text] [Related]
9. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease]. Maurel F; Lilliu H; Le Pen C Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770 [TBL] [Abstract][Full Text] [Related]
10. What may be gained from neuropsychological investigations of tardive dyskinesia? Cohen H; Cohen D Brain Cogn; 1993 Sep; 23(1):1-7. PubMed ID: 8105818 [TBL] [Abstract][Full Text] [Related]
14. The prognosis of tardive dyskinesia. Gardos G; Cole JO J Clin Psychiatry; 1983 May; 44(5):177-9. PubMed ID: 6133847 [TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia: a review and current treatment options. Najib J Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647 [TBL] [Abstract][Full Text] [Related]
16. The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS). Matson JL; Fodstad JC; Rivet TT J Intellect Dev Disabil; 2008 Dec; 33(4):337-44. PubMed ID: 19039694 [TBL] [Abstract][Full Text] [Related]
17. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825 [TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia and ethnicity: review of the literature. Swartz JR; Burgoyne K; Smith M; Gadasally R; Ananth J; Ananth K Ann Clin Psychiatry; 1997 Mar; 9(1):53-9. PubMed ID: 9167836 [TBL] [Abstract][Full Text] [Related]
19. Buspirone in the treatment of tardive dyskinesia. Moss LE; Neppe VM; Drevets WC J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622 [TBL] [Abstract][Full Text] [Related]
20. [Tardive dyskinesia: review of the literature]. Carta MG; Hardoy MC; Dell'Osso L; Carpiniello B Clin Ter; 2004 Apr; 155(4):127-33. PubMed ID: 15354761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]